Phio Pharmaceuticals Corp Stock Fundamentals
| PHIO Stock | USD 0.64 0.01 1.54% |
Phio Pharmaceuticals Corp fundamentals help investors to digest information that contributes to Phio Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Phio Stock. The fundamental analysis module provides a way to measure Phio Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Phio Pharmaceuticals stock.
At this time, Phio Pharmaceuticals' Interest Expense is very stable compared to the past year. As of the 19th of April 2024, Preferred Stock And Other Adjustments is likely to grow to about 3 M, while Depreciation And Amortization is likely to drop about 115.8 K. Phio | Select Account or Indicator |
Phio Pharmaceuticals Corp Company Return On Equity Analysis
Phio Pharmaceuticals' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Phio Pharmaceuticals Return On Equity | -1.17 |
Most of Phio Pharmaceuticals' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Phio Pharmaceuticals Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Phio Total Stockholder Equity
Total Stockholder Equity |
|
Based on the latest financial disclosure, Phio Pharmaceuticals Corp has a Return On Equity of -1.166. This is 95.14% lower than that of the Biotechnology sector and 96.8% lower than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.
Phio Pharmaceuticals Corp Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Phio Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Phio Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Phio Pharmaceuticals competition to find correlations between indicators driving Phio Pharmaceuticals's intrinsic value. More Info.Phio Pharmaceuticals Corp is rated below average in return on equity category among related companies. It is rated below average in return on asset category among related companies . At this time, Phio Pharmaceuticals' Return On Equity is very stable compared to the past year.Comparative valuation analysis is a catch-all model that can be used if you cannot value Phio Pharmaceuticals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Phio Pharmaceuticals' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Phio Pharmaceuticals' earnings, one of the primary drivers of an investment's value.Phio Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Phio Pharmaceuticals' direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Phio Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Phio Pharmaceuticals by comparing valuation metrics of similar companies.Phio Pharmaceuticals is currently under evaluation in return on equity category among related companies.
Phio Fundamentals
| Return On Equity | -1.17 | ||||
| Return On Asset | -0.6 | ||||
| Current Valuation | (5.53 M) | ||||
| Shares Outstanding | 4.59 M | ||||
| Shares Owned By Insiders | 0.59 % | ||||
| Shares Owned By Institutions | 11.00 % | ||||
| Number Of Shares Shorted | 21.39 K | ||||
| Price To Earning | (0.80) X | ||||
| Price To Book | 0.40 X | ||||
| Price To Sales | 48.01 X | ||||
| Gross Profit | (7.01 M) | ||||
| EBITDA | (10.51 M) | ||||
| Net Income | (10.83 M) | ||||
| Cash And Equivalents | 18.02 M | ||||
| Cash Per Share | 1.32 X | ||||
| Total Debt | 35 K | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 6.48 X | ||||
| Book Value Per Share | 2.06 X | ||||
| Cash Flow From Operations | (10.75 M) | ||||
| Short Ratio | 0.04 X | ||||
| Earnings Per Share | (5.20) X | ||||
| Target Price | 4.0 | ||||
| Beta | 1.42 | ||||
| Market Capitalization | 2.93 M | ||||
| Total Asset | 9.36 M | ||||
| Retained Earnings | (139.21 M) | ||||
| Working Capital | 7.69 M | ||||
| Current Asset | 9.23 M | ||||
| Current Liabilities | 2.17 M | ||||
| Net Asset | 9.36 M |
About Phio Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Phio Pharmaceuticals Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Phio Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Phio Pharmaceuticals Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 1.4 M | 1.5 M | |
| Total Revenue | 0.00 | 0.00 | |
| Cost Of Revenue | 184 K | 174.8 K | |
| Stock Based Compensation To Revenue | 16.43 | 21.55 | |
| Sales General And Administrative To Revenue | 201.77 | 211.86 | |
| Research And Ddevelopement To Revenue | 184.29 | 94.68 | |
| Capex To Revenue | (3.94) | (4.14) | |
| Revenue Per Share | 0.63 | 0.60 | |
| Ebit Per Revenue | (492.15) | (516.75) |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Phio Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Phio Pharmaceuticals' short interest history, or implied volatility extrapolated from Phio Pharmaceuticals options trading.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Phio Pharmaceuticals Corp using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Phio Pharmaceuticals Piotroski F Score and Phio Pharmaceuticals Altman Z Score analysis. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Complementary Tools for Phio Stock analysis
When running Phio Pharmaceuticals' price analysis, check to measure Phio Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Phio Pharmaceuticals is operating at the current time. Most of Phio Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Phio Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Phio Pharmaceuticals' price. Additionally, you may evaluate how the addition of Phio Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |
Is Phio Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Phio Pharmaceuticals. If investors know Phio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Phio Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.20) | Return On Assets (0.60) | Return On Equity (1.17) |
The market value of Phio Pharmaceuticals Corp is measured differently than its book value, which is the value of Phio that is recorded on the company's balance sheet. Investors also form their own opinion of Phio Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Phio Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Phio Pharmaceuticals' market value can be influenced by many factors that don't directly affect Phio Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Phio Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Phio Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Phio Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.